Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Surgical Innovations Group plc (LSE:SUN) Focuses on Precision Tip Insulation Integrity in Resposable Instruments in the FTSE AIM All-Share

The operational framework of Surgical Innovations combines direct commercialBrandsales with high-volume original equipment manufacturing (OEM) partnerships. Through strategic distribution alliances with multinational healthcare corporations and regional distributors across the United Kingdom, Europe, and North America, the group distributes its flagship YelloPort and Resposable product …

Ankur Sharma | 16 November 2026

Why Kromek Group Plc (LSE:KMK) Focuses on Low-Noise Readout Electronics for Medical SPECT Imaging Detectors in the FTSE AIM All-Share

The primary growth catalyst for Kromek is expanding procurementDemandfrom governmental defense agencies and homeland security authorities worldwide. The company manufactures handheld radiation detectors, drone-mountable sensor packages, and biological threat detection platforms, including the D3S and D5 RIID platforms deployed across civilian infrastructure and border …

Ankur Sharma | 16 November 2026

What Mendell Helium Plc (LSE:MDH) Disclosed Regarding Helium Purification Membrane Efficiency in Pilot Testing

The flagship operational asset for Mendell Helium (LSE:MDH) is its acreage position across the Hugoton Gas Field in Kansas, United States. In recent corporate announcements, management confirmed the execution of drilling, logging, andWell Completionoperations at its Rost 1-26, Rost 2-26, and Brobee project locations.Well …

Ankur Sharma | 16 November 2026

What Metir plc (LSE:MET) Outlined for PFAS Water Monitoring Technology

Management has carried out a disciplined rationalisation programme across its facilities and product lines. The company divested peripheral digitalAssetsto focus engineering resources on field-deployable fluorometric water testing systems and toxicity monitors. By standardising sensorManufacturingprocesses and consolidating distribution partnerships in key municipal water sectors, Metir …

Ankur Sharma | 16 November 2026

Why Nuformix plc (LSE:NFX) Prioritises Intellectual Property Filings for Novel Cocrystal Fibrosis Formulations

The flagship clinical development asset within Nuformix's proprietary pipeline is NXP002, a novel proprietary formulation of tranilast delivered via inhalation for the treatment of idiopathic pulmonary fibrosis (IPF). By administering tranilast directly to the lung tissue via inhalation rather than systemic oral dosing, NXP002 …

Ankur Sharma | 16 November 2026

What Oxford BioDynamics Plc (LSE:OBD) Disclosed Concerning Episwitch CiRT Immunotherapy Response Test Turnaround in the FTSE AIM All-Share

The flagship commercial diagnostic product for Oxford BioDynamics (LSE:OBD) is the EpiSwitch Prostate Screening (PSE) test. Designed to improve upon the notoriously inaccurate PSA blood test, the EpiSwitch PSE test combines traditional PSA measurement with specific epigenetic chromosome conformations, achieving an notable 94% diagnostic …

Ankur Sharma | 16 November 2026

What Ondine Biomedical, Inc. (LSE:OBI) Outlined for Intensive Care Unit Photodisinfection Rollout Protocols in the FTSE AIM All-Share

Ondine has secured expanding commercial adoption across United Kingdom NHS hospital trusts and international health networks. Traditional pre-operative nasal decolonisation relies on topical antibiotic ointments such as mupirocin, which suffer from poor patient compliance and growing bacterial resistance. Steriwave replaces this regimen with a …

Ankur Sharma | 16 November 2026

How OptiBiotix Health PLC (LSE:OPTI) Validates Satiety Hormone Modulation Across Commercial SlimBiome Blends in the FTSE AIM All-Share

The commercial core of OptiBiotix'sRevenuegeneration rests upon its patented functional food ingredient platforms, notably SlimBiome® for weight management and WellBiome® for gut and immune health. By partnering with leading consumer packaged goods manufacturers, pharmaceutical corporations, and regional distributor networks, OptiBiotix supplies bulk functional ingredients …

Ankur Sharma | 16 November 2026

What Oxford BioMedica plc (LSE:OXB) Reported Regarding Viral Vector Analytical Release Testing Turnaround Times in the FTSE 250

To establish true global scale and serve transatlantic pharmaceutical clients, Oxford Biomedica has expanded its manufacturing and laboratory footprint across three key jurisdictions: the United Kingdom (Oxford), the United States (Bedford, Massachusetts), and France (Lyon). This geographicalDiversificationallows the company to support client programmes seamlessly …

Ankur Sharma | 16 November 2026

Why Probiotix Health Plc (LSE:PBX) Emphasises Human Microbiome Strain Viability Across Ambient Shelf-Life Studies

The engine of ProBiotix'sRevenueacceleration is its business-to-business ingredientSupplymodel. In major overseas consumer markets, including North America, Europe, and Asia, ProBiotix supplies bulk LPLDL powder to pharmaceutical corporations, dietary supplementBrandowners, and dairy food manufacturers. A key strategic driver has been expanding commercial distribution in China …

Ankur Sharma | 16 November 2026
Support

Hi! How can we help you today?

Loading…